Dr. John Cush RheumNow
7 years 4 months ago
Prospective study of 4796 pts in the Osteoarthritis Initiative shows metformin use in obese pts (BMI>30) was Assoc with significantly less medial cartilage loss (0.71% vs. 1.57%/yr) & a trend towards fewer knee replacements over 6 yrs (OR 0.30, p = 0.11) https://t.co/LD0jFWtSLM
Dr. John Cush RheumNow
7 years 4 months ago
Japanese study 198 systemic sclerosis pts finds higher skin thickness scores (modified Rodnan Skin Scores; mRSS) associated with higher risk of interstitial lung disease (P < 0.05), restrictive LDz(P < 0.01), and diffusion impairment (P < 0.05) https://t.co/PY4n6N5Ub9
The American College of Rheumatology (ACR) Board of Directors is pleased to announce that Steven C. Echard, IOM, CAE is the new Executive Vice President (EVP) of the American College of Rheumatology. Echard was offered the position in March of this year after a comprehensive, nationwide search that was conducted prior to announcing the departure of long-time EVP Mark Andrejeski.
Dr. John Cush RheumNow
7 years 4 months ago
Korean National Health Insurance data compared the risk of CV events in 39,640 gout pts starting allopurinol or febuxostat. MACE incidence was 1.89 vs 1.84/100PY (HR 1.09; 0.90, 1.32) Thus, no significant difference in CV risk with these agents in Asians https://t.co/l316siAqd8
Dr. John Cush RheumNow
7 years 4 months ago
Alopecia areata pts have a higher risk of mortality assoc w/ self-harm, psychiatric dz (HR, 1.21) & smoking-associated malignant diseases including lung cancer (HR, 2.16), but not all cause mortality. Increases higher w/ Alopecia totalis/universalis. https://t.co/idVGmSTcRE
Dr. Jack Cush presents the news and best of rheumatology and medicine from the past week on RheumNow.com
Rituximab (Rituxan) may be an option for maintenance therapy in patients with difficult-to-treat systemic lupus erythematosus (SLE), European researchers reported.
Dr. John Cush RheumNow
7 years 4 months ago
In a study of 678 first-degree relatives (FDRs) of RA patients and 330 osteoarthritis (OA) subjects, increasing age is associated with increasing positive results for the CCP3.1 and CCP-IgA test results - just like RF. https://t.co/0iwK0CjxUj
An article in the Annals of Internal Medicine has analyzed the cost-consequences of physician burnout, including costs related to physician turnover and reduced clinical hours.
Dr. John Cush RheumNow
7 years 4 months ago
184 juvenile Fibromyalga pts randomized to PBO or duloxetine (30-->60mg/d) for 13wks. Those on duloxetine failed the primary endpoint - mean 24 hr change in Brief Pain Inventory (BPI), but more Cymbalt pts had 30% nd 50% BPI reductions https://t.co/EuyCRqKzN7
Dr. John Cush RheumNow
7 years 4 months ago
Japanese study 198 systemic sclerosis pts finds that higher skin thickness scores (modified Rodnan Skin Scores; mRSS) associated with higher risk of interstitial lung disease (P < 0.05), restrictive LDz(P < 0.01), and diffusion impairment (P < 0.05) https://t.co/PY4n6N5Ub9
A EULAR task force has reviewed the medical literature and developed evidence-based recommendations for the management of antiphospholipid syndrome (APS) in adults. They note that a high-risk antiphospholipid antibody (aPL) profile is associated with greater risk for thrombotic and obstetric APS.
Dr. John Cush RheumNow
7 years 4 months ago
FDA is seeking public input into CBD - cannabidiol - and will be holding a public hearing on CBD this friday May 31st. https://t.co/00MYFNESQ3
Dr. John Cush RheumNow
7 years 4 months ago
Risk factors for gouty tophi that ulcerate include: glucocorticoid overuse, tophi duration, and the number of tophi. Based on a chinese study of 105 tophaceous patients of whom 33 developed ulcerations https://t.co/rzYTFCb5jk
